All News
Filter News
Found 7,642 articles
-
Amgen Teams Up with Roche and Merck & Co. on Combination Drug Cancer Trials
6/2/2015
-
Baxter International Launches a Vitesse Biologics in South San Francisco
6/2/2015
-
Hospira Release: ANVISA Approves First Infliximab Biosimilar In Brazil
6/2/2015
-
EMD Millipore Introduces Compaction Technology To Improve Solubility And Facilitate Handling Of Cell Culture Media Used In Biopharmaceutical Production
6/2/2015
-
The Most Exciting Companies in Biotech
6/1/2015
-
ASCO15: Momenta To Present New Data From Phase 1 Trial Of Necuparanib In Patients With Pancreatic Cancer
6/1/2015
-
EMD Millipore Launches Cellvento CHO Cell Culture Media Platform For Optimized Cell Growth And Productivity
6/1/2015
-
Baxter Ventures, Mayo Clinic And Velocity Pharmaceutical Development Announce The Formation Of Vitesse Biologics, LLC, A Company Structured To Accelerate Therapeutic Innovation
6/1/2015
-
Pediatric Praziquantel Consortium Awarded USD4.9 Million Grant From Global Health Innovative Technology Fund
5/29/2015
-
BioPharm Executive: Here's How The Drug Industry Will Finally Hang Itself
5/28/2015
-
Merck KGaA, Darmstadt, Germany, As Pioneer In Assisted Reproductive Treatments, Takes Leading Role In Fertility Technologies, Announces A Global Collaboration Agreement With Genea Biomedx
5/28/2015
-
amp biosimilars AG Successfully Out-Licenses First Biosimilar
5/28/2015
-
Merck Serono As Pioneer In Assisted Reproductive Treatments Takes Leading Role In Fertility Technologies Signing A Global Collaboration Agreement With Genea Biomedx
5/28/2015
-
EMD Serono Continues Its Entry Into Oncology With The Key Appointments Of David Trexler To Senior Vice President Of Oncology Commercial And Zhen Su, MD, MBA To Vice President Of Medical Oncology
5/28/2015
-
Updated Time - Flamel Technologies To Present At Jefferies and Co. 2015 Healthcare Conference
5/28/2015
-
Immune Pharmaceuticals, Inc. To Present At Goldman, Sachs & Co. Immuno-Oncology Business Development (BD&L) And Investment Forum In Chicago And At Marcum Conference In New York
5/28/2015
-
Johnson & Johnson Announced 10 New Approval Applications with $1 Billion Revenue Potential Each
5/27/2015
-
Coherus To Present At Jefferies and Co. Healthcare Conference On June 3
5/27/2015
-
Flamel Technologies To Present At Jefferies and Co. 2015 Healthcare Conference
5/26/2015
-
BIO Release: North Carolina Governor McCrory Signs Bill Ensuring Patient Access To Interchangeable Biologic Medicines
5/22/2015